annual current liabilities:
$30.21B+$5.07B(+20.15%)Summary
- As of today (August 20, 2025), NVO annual total current liabilities is $30.21 billion, with the most recent change of +$5.07 billion (+20.15%) on December 31, 2024.
- During the last 3 years, NVO annual current liabilities has risen by +$14.99 billion (+98.51%).
- NVO annual current liabilities is now at all-time high.
Performance
NVO Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$32.65B-$1.54B(-4.49%)Summary
- As of today (August 20, 2025), NVO quarterly total current liabilities is $32.65 billion, with the most recent change of -$1.54 billion (-4.49%) on June 1, 2025.
- Over the past year, NVO quarterly current liabilities has increased by +$5.65 billion (+20.90%).
- NVO quarterly current liabilities is now -4.49% below its all-time high of $34.19 billion, reached on March 31, 2025.
Performance
NVO quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
NVO Current liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +20.1% | +20.9% |
3 y3 years | +98.5% | +111.8% |
5 y5 years | +240.9% | +222.0% |
NVO Current liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +98.5% | -4.5% | +111.8% |
5 y | 5-year | at high | +240.9% | -4.5% | +222.0% |
alltime | all time | at high | >+9999.0% | -4.5% | >+9999.0% |
NVO Current liabilities History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $32.65B(-4.5%) |
Mar 2025 | - | $34.19B(+13.2%) |
Dec 2024 | $30.21B(+20.1%) | $30.21B(-3.2%) |
Sep 2024 | - | $31.19B(+15.5%) |
Jun 2024 | - | $27.01B(+12.6%) |
Mar 2024 | - | $23.98B(-4.6%) |
Dec 2023 | $25.14B(+44.8%) | $25.14B(+2.6%) |
Sep 2023 | - | $24.50B(+6.8%) |
Jun 2023 | - | $22.95B(+19.2%) |
Mar 2023 | - | $19.25B(+10.9%) |
Dec 2022 | $17.36B(+14.1%) | $17.36B(+1.1%) |
Sep 2022 | - | $17.16B(+11.3%) |
Jun 2022 | - | $15.42B(+7.8%) |
Mar 2022 | - | $14.30B(-6.0%) |
Dec 2021 | $15.22B(+31.7%) | $15.22B(+10.5%) |
Sep 2021 | - | $13.77B(+18.6%) |
Jun 2021 | - | $11.61B(+1.5%) |
Mar 2021 | - | $11.44B(-1.0%) |
Dec 2020 | $11.55B(+30.4%) | $11.55B(+3.4%) |
Sep 2020 | - | $11.18B(+10.2%) |
Jun 2020 | - | $10.14B(+9.1%) |
Mar 2020 | - | $9.29B(+4.9%) |
Dec 2019 | $8.86B(+6.8%) | $8.86B(-3.8%) |
Sep 2019 | - | $9.21B(+6.7%) |
Jun 2019 | - | $8.64B(+4.8%) |
Mar 2019 | - | $8.24B(-0.7%) |
Dec 2018 | $8.30B(+9.3%) | $8.30B(+7.8%) |
Sep 2018 | - | $7.70B(-0.1%) |
Jun 2018 | - | $7.71B(+5.8%) |
Mar 2018 | - | $7.29B(-4.0%) |
Dec 2017 | $7.59B(+12.8%) | $7.59B(+5.9%) |
Sep 2017 | - | $7.17B(+6.6%) |
Jun 2017 | - | $6.72B(-4.4%) |
Mar 2017 | - | $7.03B(+4.5%) |
Dec 2016 | $6.73B(+13.1%) | $6.73B(+7.2%) |
Sep 2016 | - | $6.28B(+1.2%) |
Jun 2016 | - | $6.20B(-1.3%) |
Mar 2016 | - | $6.28B(+5.6%) |
Dec 2015 | $5.95B(+8.7%) | $5.95B(+3.2%) |
Sep 2015 | - | $5.76B(-0.0%) |
Jun 2015 | - | $5.76B(-4.5%) |
Mar 2015 | - | $6.04B(+10.3%) |
Dec 2014 | $5.47B(+22.4%) | $5.47B(+7.4%) |
Sep 2014 | - | $5.10B(+16.9%) |
Jun 2014 | - | $4.36B(-10.5%) |
Mar 2014 | - | $4.87B(+8.9%) |
Dec 2013 | $4.47B(+17.0%) | $4.47B(-3.9%) |
Sep 2013 | - | $4.66B(+5.1%) |
Jun 2013 | - | $4.43B(+0.4%) |
Mar 2013 | - | $4.41B(+15.4%) |
Dec 2012 | $3.82B(+5.4%) | $3.82B(-15.5%) |
Sep 2012 | - | $4.53B(+11.2%) |
Jun 2012 | - | $4.07B(+3.4%) |
Mar 2012 | - | $3.94B(+8.5%) |
Dec 2011 | $3.63B | $3.63B(-1.1%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2011 | - | $3.67B(+1.5%) |
Jun 2011 | - | $3.62B(+4.1%) |
Mar 2011 | - | $3.47B(+4.4%) |
Dec 2010 | $3.33B(+28.6%) | $3.33B(+7.2%) |
Sep 2010 | - | $3.10B(+3.1%) |
Jun 2010 | - | $3.01B(+6.6%) |
Mar 2010 | - | $2.82B(+9.1%) |
Dec 2009 | $2.59B(+6.9%) | $2.59B(+1.8%) |
Sep 2009 | - | $2.54B(+8.1%) |
Jun 2009 | - | $2.35B(-6.8%) |
Mar 2009 | - | $2.52B(+4.2%) |
Dec 2008 | $2.42B(+16.0%) | $2.42B(+4.4%) |
Sep 2008 | - | $2.32B(-0.5%) |
Jun 2008 | - | $2.33B(-5.5%) |
Mar 2008 | - | $2.46B(+18.1%) |
Dec 2007 | $2.09B(+16.1%) | $2.09B(+1.6%) |
Sep 2007 | - | $2.05B(+7.3%) |
Jun 2007 | - | $1.91B(+0.6%) |
Mar 2007 | - | $1.90B(+5.9%) |
Dec 2006 | $1.80B(+7.4%) | $1.80B(-7.9%) |
Sep 2006 | - | $1.95B(+11.4%) |
Jun 2006 | - | $1.75B(+2.8%) |
Mar 2006 | - | $1.70B(+1.8%) |
Dec 2005 | $1.67B(+25.8%) | $1.67B(+11.1%) |
Sep 2005 | - | $1.51B(+3.6%) |
Jun 2005 | - | $1.45B(+11.9%) |
Mar 2005 | - | $1.30B(-2.4%) |
Dec 2004 | $1.33B(+15.1%) | $1.33B(+9.6%) |
Sep 2004 | - | $1.21B(+11.0%) |
Jun 2004 | - | $1.09B(-5.2%) |
Mar 2004 | - | $1.15B(-0.2%) |
Dec 2003 | $1.16B(+37.0%) | $1.16B(+37.0%) |
Dec 2002 | $843.27M(+17.2%) | $843.27M(+17.2%) |
Dec 2001 | $719.25M(-10.8%) | $719.25M(-10.8%) |
Dec 2000 | $806.55M(-8.7%) | $806.55M(+5.9%) |
Dec 1999 | $883.44M(+2.5%) | $761.33M(-11.4%) |
Dec 1998 | $861.97M(+11.4%) | $858.95M(+10.2%) |
Dec 1997 | $773.72M(-6.8%) | $779.56M(-5.6%) |
Dec 1996 | $830.15M(-1.4%) | $825.71M(+16.4%) |
Dec 1995 | $841.75M(+11.8%) | $709.25M(-5.8%) |
Dec 1994 | $752.77M(+38.8%) | $752.74M(+38.1%) |
Dec 1993 | $542.28M(-0.9%) | $545.20M(-0.4%) |
Dec 1992 | $547.26M(-16.1%) | $547.28M(-16.1%) |
Dec 1991 | $652.04M(-9.6%) | $652.11M(-9.5%) |
Dec 1990 | $721.22M(+30.3%) | $720.85M(+30.8%) |
Dec 1989 | $553.47M(+39.9%) | $551.25M(+39.1%) |
Dec 1988 | $395.54M(+14.5%) | $396.36M(+14.2%) |
Dec 1987 | $345.40M(+15.6%) | $347.05M(+16.2%) |
Dec 1986 | $298.70M(+67.1%) | $298.79M(+67.2%) |
Dec 1985 | $178.77M(+7.9%) | $178.69M(+7.8%) |
Dec 1984 | $165.74M(+18.5%) | $165.83M |
Dec 1983 | $139.89M(+12.8%) | - |
Dec 1982 | $124.06M(+14.4%) | - |
Dec 1981 | $108.43M(+12.1%) | - |
Dec 1980 | $96.69M | - |
FAQ
- What is Novo Nordisk A/S annual total current liabilities?
- What is the all time high annual current liabilities for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual current liabilities year-on-year change?
- What is Novo Nordisk A/S quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly current liabilities year-on-year change?
What is Novo Nordisk A/S annual total current liabilities?
The current annual current liabilities of NVO is $30.21B
What is the all time high annual current liabilities for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual total current liabilities is $30.21B
What is Novo Nordisk A/S annual current liabilities year-on-year change?
Over the past year, NVO annual total current liabilities has changed by +$5.07B (+20.15%)
What is Novo Nordisk A/S quarterly total current liabilities?
The current quarterly current liabilities of NVO is $32.65B
What is the all time high quarterly current liabilities for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly total current liabilities is $34.19B
What is Novo Nordisk A/S quarterly current liabilities year-on-year change?
Over the past year, NVO quarterly total current liabilities has changed by +$5.65B (+20.90%)